Clinical trials recruiting for Her 2 Positive Breast Cancer
4
Recruiting trials
2
US states with sites
4
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2Not applicable 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| A166 | 1 |
| Concurrent endocrine therapy with the chemotherapy and HER2 directed therapy | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Oregon | 1 |
| Washington | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of A166 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer
- Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer
- HER2+ CNS Surveillance
- Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease
Related conditions
Trials recruiting for Her 2 Positive Breast Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Her 2 Positive Breast Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.